Author:
Liu Chang,Tu Yi-jun,Cai Hong-Yang,Pan Yan-yan,Wu Yuan-yuan,Zhang Li
Abstract
Abstract
Purpose
Tumor initiating cells (TICs) or cancer stem cells (CSCs) are considered to be the main culprit of hepatocellular carcinoma (HCC) initiation and progression, nevertheless the mechanism by which tumor microenvironment maintains the HCC ‘stemness’ is not fully understood. This study aims to investigate the effect of regulatory T cells (Tregs) on the TICs characteristics of HCC.
Methods
Immunocytochemistry, flow cytometry, real-time PCR, western blot, in vitro sphere-formation, and in vivo tumorigenesis assay were used to detect HCC ‘stemness’. Additionally, after forced expression or inhibition of FoxP3, β-catenin expression and HCC ‘stemness’ were investigated.
Results
Tregs enhanced the ‘stemness’ of HCC cells by upregulating TIC-related markers CD133, Oct3/4, Sox2, c-Myc, Klf4, Nanog, CD13, EpCAM, and inducting epithelial to mesenchymal transition (EMT), increasing TICs ratio, as well as promoting tumorigenic ability. Moreover, β-catenin and c-Myc were upregulated in HCC cells after co-cultured with Tregs. HCC ‘stemness’ was inhibited after treatment with Wnt/β-catenin pathway inhibitor. Furthermore, forced expression of FoxP3 resulted in increased GSK3β, decreased β-catenin and TIC ratio in HCC. In contrast, FoxP3 interference reduced GSK3β, enhanced β-catenin and TIC ratio of HCC.
Conclusion
This study, for the first time, demonstrated that Tregs increased the population of TICs in HCC by inhibiting FoxP3 as well as promoting β-catenin expression.
Funder
National Natural Science Foundation of China
Dalian Science and Technology Bureau
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Chen J, Jin R, Zhao J, Liu J, Ying H, Yan H (2015) Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma. Cancer Lett 367:1–11
2. Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B (2007) Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 32:2328–2339
3. Grimmig T, Kim M, Germer CT, Gasser M, Waaga-Gasser AM (2013) The role of FOXP3 in disease progression in colorectal cancer patients. Oncoimmunology 2:e24521
4. Guo JC, Yang YJ, Zheng JF, Zhang JQ, Guo M, Yang X et al (2019) Silencing of long noncoding RNA HOXA11-AS inhibits the wnt signaling pathway via the upregulation of HOXA11 and thereby inhibits the proliferation, invasion, and self-renewal of hepatocellular carcinoma stem cells. Exp Mol Med 51:142
5. Hassan EA, Ahmed EH, Nafee AM, El-Gafary N, Hetta HF, El-Mokhtar MA (2019) Regulatory T cells, IL10 and IL6 in HCV related Hepatocellular Carcinoma after Transarterial Chemoembolization (TACE). Egypt J Immunol 26:69–78
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献